Results 171 to 180 of about 28,246 (219)
Some of the next articles are maybe not open access.
Hematology/Oncology Clinics of North America, 1996
The association of cancer with a hypercoagulable state is documented by numerous clinical, biochemical, pathologic, and pharmacologic studies. This association is manifested clinically by an increased incidence of intravascular thrombotic events in cancer patients and by fibrin deposition in and around tumor beds.
K B, Green, R L, Silverstein
openaire +2 more sources
The association of cancer with a hypercoagulable state is documented by numerous clinical, biochemical, pathologic, and pharmacologic studies. This association is manifested clinically by an increased incidence of intravascular thrombotic events in cancer patients and by fibrin deposition in and around tumor beds.
K B, Green, R L, Silverstein
openaire +2 more sources
Annals of Internal Medicine, 1985
Patients are considered to have hypercoagulable states if they have laboratory abnormalities or clinical conditions that are associated with an increased risk of thrombosis (prethrombotic states) or if they have recurrent thrombosis without recognizable predisposing factors (thrombosis-prone).
openaire +2 more sources
Patients are considered to have hypercoagulable states if they have laboratory abnormalities or clinical conditions that are associated with an increased risk of thrombosis (prethrombotic states) or if they have recurrent thrombosis without recognizable predisposing factors (thrombosis-prone).
openaire +2 more sources
Southern Medical Journal, 2001
This review emphasizes pathophysiology, clinical features, assessment, and therapy for hypercoagulability. Risk factors that further increase clotting include obesity, recent surgery, pregnancy, and cancer. Clinical examples of coagulation abnormalities may occur from single or multiple abnormalities and include both inherited and acquired defects ...
N, Abramson, S, Abramson
openaire +2 more sources
This review emphasizes pathophysiology, clinical features, assessment, and therapy for hypercoagulability. Risk factors that further increase clotting include obesity, recent surgery, pregnancy, and cancer. Clinical examples of coagulation abnormalities may occur from single or multiple abnormalities and include both inherited and acquired defects ...
N, Abramson, S, Abramson
openaire +2 more sources
Hypercoagulation and Thrombosis
Medical Clinics of North America, 1980As knowledge of blood coagulation has advanced we have begun to examine not only the clinical entities associated with hemorrhage but also a group in which thrombosis represents the major problem. Thrombotic disorders believed to be associated with coagulation are recognized clinically but seldom investigated in the laboratory. The present approach to
openaire +2 more sources
Hospital Practice, 1993
In most cases, acute venous thrombosis has a straightforward etiology--for example, the patient who has had prolonged bed rest with a broken leg and received no heparin. A significant minority of patients, however, have an inherited biochemical deficiency or an acquired disorder that increases the risk of thrombosis.
openaire +2 more sources
In most cases, acute venous thrombosis has a straightforward etiology--for example, the patient who has had prolonged bed rest with a broken leg and received no heparin. A significant minority of patients, however, have an inherited biochemical deficiency or an acquired disorder that increases the risk of thrombosis.
openaire +2 more sources
The hypercoagulable state in thalassemia
Blood, 2002Thalassemia is a congenital hemolytic disorder caused by a partial or complete deficiency of α- or β-globin chain synthesis. Homozygous carriers of β-globin gene defects suffer from severe anemia and other serious complications from early childhood. The disease is treated by chronic blood transfusion.
Amiram, Eldor, Eliezer A, Rachmilewitz
openaire +2 more sources
The Hypercoagulability of Polycythemia Vera
Hospital Practice, 1993Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.
W, Fields, N J, Freeman
openaire +2 more sources
Mechanisms of Hypercoagulability
Thrombosis and Haemostasis, 1999IntroductionPatients undergoing major traumas, major joint replacement surgery, and neurosurgery are at high risk for postoperative deep vein thrombosis (DVT). Even if modern low molecular weight heparin is given as prophylaxis, the frequency of DVT remains high in these patients.1-7 This may indicate that some patients possess a certain “heparin ...
openaire +2 more sources
Hypercoagulability in Arterial Disease
Angiology, 1989Isolated human monocytes generate tissue factor when stimulated with endo toxin. Tissue factor generation provides a marker for activation of the monocyte and of the clotting system. Determination of the recalcification time of blood after incubation with endotoxin detects minute changes in coagulability.
C R, Spillert +3 more
openaire +2 more sources
Hypercoagulability in the nephrotic syndrome
Klinische Wochenschrift, 1980The risk of thromboembolic complications in patients with the nephrotic syndrome (NS) is higher than in any other condition encountered in internal medicine. Such thromboembolic complications comprise venous thromboses (calf, thigh, renal vein) with or without pulmonary embolism and arterial thromboses (coronary thromboses, cerebral artery thromboses ...
K, Andrassy, E, Ritz, J, Bommer
openaire +2 more sources